Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).
|06/04/12||S-1/A||General form of registration statement for all companies including face-amount certificate companies
|05/17/12||CORRESP||A correspondence can be sent as a document with another submission type or can be sent as a separate submission.||3|
|05/15/12||10-Q||Quarterly report pursuant to sections 13 or 15(d)||29|
|05/11/12||8-K/A||Current report filing||5|
|05/10/12||8-K||Current report filing||5|
|05/04/12||8-K||Current report filing||6|
|05/02/12||8-K||Current report filing||23|
|04/26/12||S-1||General form of registration statement for all companies including face-amount certificate companies||114|